PTC India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 8, 2025, 3:39 am

Competitors of PTC India Ltd

All Competitor Stocks of PTC India Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:00 am

Below is a detailed analysis of the quarterly data for PTC India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 4,009.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,924.00 Cr. (Mar 2025) to 4,009.00 Cr., marking an increase of 1,085.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,721.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,768.00 Cr. (Mar 2025) to 3,721.00 Cr., marking an increase of 953.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 288.00 Cr.. The value appears strong and on an upward trend. It has increased from 156.00 Cr. (Mar 2025) to 288.00 Cr., marking an increase of 132.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Mar 2025) to 7.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 95.00 Cr.. The value appears to be declining and may need further review. It has decreased from 421.00 Cr. (Mar 2025) to 95.00 Cr., marking a decrease of 326.00 Cr..
• For Interest, as of Jun 2025, the value is 92.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 99.00 Cr. (Mar 2025) to 92.00 Cr., marking a decrease of 7.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 289.00 Cr.. The value appears to be declining and may need further review. It has decreased from 475.00 Cr. (Mar 2025) to 289.00 Cr., marking a decrease of 186.00 Cr..
• For Tax %, as of Jun 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Mar 2025) to 16.00%, marking a decrease of 6.00%.
• For Net Profit, as of Jun 2025, the value is 243.00 Cr.. The value appears to be declining and may need further review. It has decreased from 372.00 Cr. (Mar 2025) to 243.00 Cr., marking a decrease of 129.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.59. The value appears to be declining and may need further review. It has decreased from 11.88 (Mar 2025) to 6.59, marking a decrease of 5.29.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:14 pm

Growth

Last Updated: September 5, 2025, 12:45 pm

Balance Sheet

Last Updated: June 16, 2025, 11:29 am

Below is a detailed analysis of the balance sheet data for PTC India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 296.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 296.00 Cr..
• For Reserves, as of Mar 2025, the value is 5,509.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,846.00 Cr. (Mar 2024) to 5,509.00 Cr., marking an increase of 663.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,962.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4,327.00 Cr. (Mar 2024) to 2,962.00 Cr., marking a decrease of 1,365.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,148.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,654.00 Cr. (Mar 2024) to 4,148.00 Cr., marking a decrease of 1,506.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 12,916.00 Cr.. The value appears to be improving (decreasing). It has decreased from 15,123.00 Cr. (Mar 2024) to 12,916.00 Cr., marking a decrease of 2,207.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2024) to 38.00 Cr., marking a decrease of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 377.00 Cr.. The value appears strong and on an upward trend. It has increased from 284.00 Cr. (Mar 2024) to 377.00 Cr., marking an increase of 93.00 Cr..
• For Other Assets, as of Mar 2025, the value is 12,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,796.00 Cr. (Mar 2024) to 12,500.00 Cr., marking a decrease of 2,296.00 Cr..
• For Total Assets, as of Mar 2025, the value is 12,916.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15,123.00 Cr. (Mar 2024) to 12,916.00 Cr., marking a decrease of 2,207.00 Cr..

Notably, the Reserves (5,509.00 Cr.) exceed the Borrowings (2,962.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for PTC India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 30.41. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 30.41, marking an increase of 14.30.
• For Diluted EPS (Rs.), as of Mar 25, the value is 30.41. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 30.41, marking an increase of 14.30.
• For Cash EPS (Rs.), as of Mar 25, the value is 33.21. This value is within the healthy range. It has increased from 18.23 (Mar 24) to 33.21, marking an increase of 14.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 196.11. It has decreased from 203.72 (Mar 24) to 196.11, marking a decrease of 7.61.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 196.11. It has decreased from 203.72 (Mar 24) to 196.11, marking a decrease of 7.61.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 548.65. It has decreased from 566.30 (Mar 24) to 548.65, marking a decrease of 17.65.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 39.39. This value is within the healthy range. It has increased from 37.31 (Mar 24) to 39.39, marking an increase of 2.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 36.97 (Mar 24) to 39.08, marking an increase of 2.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 37.65. This value is within the healthy range. It has increased from 21.97 (Mar 24) to 37.65, marking an increase of 15.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 32.90. This value is within the healthy range. It has increased from 17.90 (Mar 24) to 32.90, marking an increase of 15.00.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 30.41. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 30.41, marking an increase of 14.30.
• For PBDIT Margin (%), as of Mar 25, the value is 7.18. This value is below the healthy minimum of 10. It has increased from 6.58 (Mar 24) to 7.18, marking an increase of 0.60.
• For PBIT Margin (%), as of Mar 25, the value is 7.12. This value is below the healthy minimum of 10. It has increased from 6.52 (Mar 24) to 7.12, marking an increase of 0.60.
• For PBT Margin (%), as of Mar 25, the value is 6.86. This value is below the healthy minimum of 10. It has increased from 3.87 (Mar 24) to 6.86, marking an increase of 2.99.
• For Net Profit Margin (%), as of Mar 25, the value is 5.99. This value is within the healthy range. It has increased from 3.16 (Mar 24) to 5.99, marking an increase of 2.83.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.54. This value is below the healthy minimum of 8. It has increased from 2.84 (Mar 24) to 5.54, marking an increase of 2.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.50. This value is within the healthy range. It has increased from 9.27 (Mar 24) to 15.50, marking an increase of 6.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.45. This value is within the healthy range. It has increased from 12.33 (Mar 24) to 13.45, marking an increase of 1.12.
• For Return On Assets (%), as of Mar 25, the value is 6.97. This value is within the healthy range. It has increased from 3.15 (Mar 24) to 6.97, marking an increase of 3.82.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has decreased from 0.54 (Mar 24) to 0.30, marking a decrease of 0.24.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.50. This value is within the healthy range. It has decreased from 0.83 (Mar 24) to 0.50, marking a decrease of 0.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.16. It has increased from 1.06 (Mar 24) to 1.16, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 2.17. This value is within the healthy range. It has increased from 1.74 (Mar 24) to 2.17, marking an increase of 0.43.
• For Quick Ratio (X), as of Mar 25, the value is 2.17. This value exceeds the healthy maximum of 2. It has increased from 1.74 (Mar 24) to 2.17, marking an increase of 0.43.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 48.41 (Mar 24) to 0.00, marking a decrease of 48.41.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 47.42 (Mar 24) to 0.00, marking a decrease of 47.42.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 51.59 (Mar 24) to 0.00, marking a decrease of 51.59.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 52.58 (Mar 24) to 0.00, marking a decrease of 52.58.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.35. This value is within the healthy range. It has increased from 2.61 (Mar 24) to 3.35, marking an increase of 0.74.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 3. It has increased from 2.18 (Mar 24) to 2.57, marking an increase of 0.39.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,475.21. It has decreased from 8,498.49 (Mar 24) to 5,475.21, marking a decrease of 3,023.28.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.33, marking a decrease of 0.17.
• For EV / EBITDA (X), as of Mar 25, the value is 4.70. This value is below the healthy minimum of 5. It has decreased from 7.69 (Mar 24) to 4.70, marking a decrease of 2.99.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.32 (Mar 24) to 0.29, marking a decrease of 0.03.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 51.58 (Mar 24) to 0.00, marking a decrease of 51.58.
• For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 1.07 (Mar 24) to 0.83, marking a decrease of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.32 (Mar 24) to 0.29, marking a decrease of 0.03.
• For EarningsYield, as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.18, marking an increase of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness